Ex-CEO misled investors over regulatory approval for new drugs
Inside info acquired by snooping on client's computer, ASIC alleged
U.S. authorities allege biostatistician traded on cancer drug data
Former senior executive pleaded guilty to trading ahead of deteriorating results
SEC, DoJ charge six in market manipulation, insider trading schemes
Director tipped others and traded ahead of pending acquisition
U.K. regulator's proposals aim to support innovation while protecting consumers
Regulator alleges banker tipped friend to pending takeover in 2021
Streamlining reporting requirements to generate industry savings
Regulator details enforcement priorities for the year ahead